Toward a <i>NOTCH1/FBXW7/RAS/PTEN</i> –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia StudyAmélie Trinquand, Vahid Asnafi, Véronique Lhéritier et al.|Journal of Clinical Oncology|2013Cited by 252
Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL StudyAline Schmidt, Xavier Thomas, Philippe Rousselot et al.|Transplantation and Cellular Therapy|2012Cited by 149
Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangementsIlaria Tanasi, Emmanuelle Clappier, Ibrahima Ba et al.|Blood|2019Cited by 136
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Leprêtre, Hervé Dombret, Aurore Touzart et al.|Journal of Clinical Oncology|2015Cited by 98
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with <scp>l</scp>‐asparaginase: The <scp>GRAALL</scp> experienceMarie‐Anne Couturier, Aline Schmidt, Françoise Huguet et al.|American Journal of Hematology|2015Cited by 71